ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

36,498Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 5176

$3.88M Total Retail Price of All Prescriptions

Rank: 4 out of 5176

884 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

34% of this provider’s 884 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

3% of this provider’s 35,102 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

50% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$106 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
LOVAZA 1,790 1,706 10 1 43
NEXIUM 1,310 1,257 2 16
AMLODIPINE BESYLATE 1,293 1,245 3 2
METFORMIN HCL ER 1,045 1,014 10 4 57
SIMVASTATIN 965 922 5 1
DIOVAN 903 890 6 19
LOSARTAN POTASSIUM 872 821 7 14
LIDODERM 737 724 8 59
ALENDRONATE SODIUM 734 717 9 18
CELEBREX 677 647 10 80
ZOLPIDEM TARTRATE 656 641 11 17
CRESTOR 586 577 12 15
HYDROCODONE-ACETAMINOPHEN 579 549 S3 13 27
METOPROLOL SUCCINATE 527 522 14 11
CLOPIDOGREL 521 510 15 26
CLOBETASOL PROPIONATE 511 482 16 130
TAMSULOSIN HCL 495 481 17 20
LEVOFLOXACIN 493 466 18 109
EVISTA 435 395 19 65
ATORVASTATIN CALCIUM 429 408 20 9
AMMONIUM LACTATE 422 402 21 91
PLAVIX 419 417 22 29
AVODART 418 408 23 107
DIOVAN HCT 415 415 24 39
GLYBURIDE 380 376 R 25 67
METOPROLOL TARTRATE 356 331 26 6
CLOTRIMAZOLE-BETAMETHASONE 355 339 27 94
FUROSEMIDE 346 346 28 8
LOSARTAN-HYDROCHLOROTHIAZIDE 326 323 29 35
GABAPENTIN 326 311 29 21
VOLTAREN 324 313 31 97
MICARDIS 320 314 10 32 154
WARFARIN SODIUM 292 278 33 13
JANUVIA 290 278 34 25
ATENOLOL 288 268 35 12
AMOX TR-POTASSIUM CLAVULANATE 280 259 36 141
SOLARAZE 272 261 37 157
TRIAMCINOLONE ACETONIDE 266 260 38 125
OMEPRAZOLE 262 239 39 3
PATADAY 244 232 40 220
GLYBURIDE-METFORMIN HCL 228 228 R 41 76
CARVEDILOL 213 210 42 24
SYNTHROID 209 205 43 33
ZETIA 196 194 44 68
TRAMADOL HCL-ACETAMINOPHEN 196 193 44 116
BENICAR 194 192 46 100
CIPROFLOXACIN HCL 193 186 47 84
FAMOTIDINE 190 179 48 58
SYMBICORT 183 173 49 120
BYSTOLIC 183 183 49 96
DONEPEZIL HCL 182 182 51 28
MECLIZINE HCL 178 173 52 81
POLYETHYLENE GLYCOL 3350 175 168 53 74
METFORMIN HCL 173 157 54 7
CREON 171 161 55 111
ENABLEX 166 160 56 284
HYDROXYZINE HCL 166 159 R 56 213
SPIRIVA 165 153 58 54
PROPRANOLOL HCL 163 151 59 199
VYTORIN 161 158 60 152
TRIAMTERENE-HCTZ 153 150 61 86
ISOSORBIDE MONONITRATE ER 152 148 62 44
AZITHROMYCIN 150 134 63 42
LISINOPRIL 141 136 64 5
LEVOTHYROXINE SODIUM 139 132 65 4
MELOXICAM 138 122 66 53
ALLOPURINOL 136 127 67 41
POTASSIUM CHLORIDE 132 128 68 34
LIPITOR 131 127 69 51
EXELON 130 130 70 162
PATANOL 128 125 71 158
SINGULAIR 124 119 72 62
CYCLOBENZAPRINE HCL 123 120 R 73 143
DIGOXIN 122 122 74 56
SINGLE USE SWAB 122 120 74 108
RIVASTIGMINE 118 118 76 364
FLUTICASONE PROPIONATE 116 109 77 38
FENOFIBRATE 114 92 78 102
BENICAR HCT 112 112 79 110
ERYTHROMYCIN 111 110 80 482
CHLORHEXIDINE GLUCONATE 110 102 81 202
TEKTURNA 110 110 81 255
EXFORGE 110 110 81 126
FINASTERIDE 110 110 81 69
LANSOPRAZOLE 107 81 85 113
PROCTOZONE-HC 103 102 86 171
VESICARE 103 99 86 210
CLONIDINE HCL 103 93 86 79
NIASPAN 102 102 89 175
MEGACE ES 102 102 R 89 423
MONTELUKAST SODIUM 95 87 91 123
NASONEX 93 90 92 178
ZOVIRAX 91 79 93 313
LYRICA 88 88 94 133
MICARDIS HCT 87 87 95 180
FLUOCINONIDE 87 80 95 165
DICYCLOMINE HCL 86 78 97 224
WELCHOL 84 84 98 230
VIREAD 83 67 99 250
TRANSDERM-SCOP 83 76 99 453
TERAZOSIN HCL 83 73 99 158
ACTOS 81 81 102 85
NIFEDIPINE ER 81 80 102 48
DOXAZOSIN MESYLATE 80 80 104 103
PREDNISONE 80 79 104 52
ZOSTAVAX 80 79 104 219
CLARITHROMYCIN 80 78 104 451
PROAIR HFA 80 79 104 60
NAMENDA 79 79 109 47
TOBRAMYCIN 77 75 110 563
PANTOPRAZOLE SODIUM 77 72 110 61
LIDOCAINE 76 62 112 179
ATELVIA 75 74 113 146
ONGLYZA 75 75 113 153
ADVAIR DISKUS 74 71 115 32
LANTUS 74 73 115 66
VALSARTAN-HYDROCHLOROTHIAZIDE 66 65 117 292
CARBIDOPA-LEVODOPA 65 65 118 98
RESTASIS 65 56 118 353
CICLOPIROX 62 62 120 279
TRICOR 61 61 121 148
TRILIPIX 61 61 121 187
METOCLOPRAMIDE HCL 60 60 123 176
THEOPHYLLINE 59 59 124 531
DILTIAZEM 24HR CD 59 59 124 119
DIPHENOXYLATE-ATROPINE 58 54 126 603
DILTIAZEM ER 57 57 127 277
PROLIA 55 55 128 448
BARACLUDE 54 53 129 373
GLIPIZIDE XL 54 48 129 83
AMITRIPTYLINE HCL 54 49 R 129 177
QUINAPRIL HCL 53 53 132 82
CYMBALTA 53 53 132 90
KETOCONAZOLE 52 47 134 233
IBUPROFEN 52 50 134 72
INDOMETHACIN 51 46 R 136 461
URSODIOL 51 51 136 405
AZELASTINE HCL 51 46 136 267
TOBRADEX 50 47 139 613
PROMETHAZINE HCL 50 49 R 139 221
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 14, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.